PCSK9 mediates dyslipidemia induced by olanzapine treatment in schizophrenia patients.
Huang J, Xiao J, Peng Z, Shao P, Sun M, Long Y, Wang X, Shen M, Kang D, Yang Y, Peng X, Wang W, Xie P, Shao T, Zhao J, Wu R.
Huang J, et al.
Psychopharmacology (Berl). 2022 Jan;239(1):83-91. doi: 10.1007/s00213-021-06042-z. Epub 2022 Jan 14.
Psychopharmacology (Berl). 2022.
PMID: 35029705